Videos

Gerpac 2022 multimedia support Contest : Public’s choice

Find out more

Video Award 2021

Find out more

2021 Conference

P. Odou (Lille, France)
T. Schnor (Herlev, Denmark)
T. Briot (Lyon, France)
I. Kramer (Mainz, Germany)
P. Le Brun (Leiden, The Netherland)
S. Crauste-Manciet (Bordeaux, France)

F. Lagarce (Angers - France)
D. Parsons (Cambridge (MA) - USA)
D. Brossard (Paris - France)
V. Sautou (Clermont Ferrand - France)

Find out more

Video Award 2020

Find out more

2020 Conference

To view the videos of 2020 conference, you must be a GERPAC member.

Find out more

Video Award 2019

Accuracy in pharmaceutical technology
Anne Flore Dumas and her team at University Hospital Grenoble

Find out more

2019 Conference

 
Carcinogens in hospitals: identification, construction of limit values and prevention of exposures
M El Yamani,
Département santé environnement travail, Santé Publique France

Exposure of healthcare workers to cytotoxic drugs
S. N’Daw, D. Flavien, M. Philippe, H. Ogier, R. Alain
Institut National de Recherche et de Sécurité (INRS), Département Polluants et santé, rue du Morvan, CS 60027, 54519 VANDOEUVRE LES NANCY Cedex, France.
1. Pharmacie à Usage Intérieur, département conception, fabrication et contrôle du médicament, CHU Amiens- Picardie, Amiens, France.
2. Laboratoire AGIR EA 4294, Université de Picardie Jules Verne, Amiens, France

 
Best preparation practices: international convergence and divergence
S. Crauste-Manciet, University Hospital Bordeaux, France
V. Salomon, Agence Nationale de Sécurité du Médicament et des produits de santé, France
F. Sadeghipour, CHUV Lausanne, Switzerland
J-F. Bussières, University Hospital Montréal, Canada
A. Beaney, North Tees and Hartlepool NHS Foundation Trust, UK
P. Le Brun, Leiden University Medical Center, The Netherlands
P. Kienle, Cardinal Health Pennsylvanie, USA

Microbiological stability consensus Working group
Working group:
Prof. Sylvie Crauste-Manciet, France - Prof. Irene Krämer, Germany - Prof. Frederic Lagarce, France - Prof. Valerie Sautou, France - Dr Alison Beaney, UK - Dr Julian Smith, UK - Mr V’Iain Fenton-May, UK - Prof. Jean-Daniel Hecq, Belgium - Prof. Farshid Sadeghipour, Switzerland - Dr Paul Le Brun, The Netherlands

 
Formulation and stability study of low-dose midazolam capsules for clinical trial
P.N. Boivin¹, A.C. Bonnaure¹, M.A. Lester^1
1 Pharmacy department, Rennes University Hospital, Rennes, France

 
Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers
Marine Roche^1,2, MSc, PharmD ; Damien Lannoy^1,2, Ph.D., PharmD ; Florence Bourdon¹, Ph.D., PharmD ; Cécile Danel², Ph.D. ; Pierre Labalette³, Ph.D., MD ; Christophe Berneron¹, PharmD ; Nicolas Simon^1,2, Ph.D. PharmD ; Pascal Odou^1,2, Ph.D., PharmD.
¹ CHU Lille, Institut de Pharmacie, F-59000 Lille, France
² Univ. Lille, EA 7365—GRITA—Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France

 
Rapid microbiological sterility test for cytotoxic batch control: is drug complexation effective for restoring microbiological growth?
Sangnier Maïté¹, Bouguéon Guillaume^1,2, Dubois Véronique^3,4, Crauste-Manciet Sylvie^1,2
(1) Pharmaceutical Technology Department, Bordeaux university hospital (CHU de Bordeaux), France
(2) ARNA Laboratory-ChemBioPharm U1212 INSERM - UMR5320, CNRS - University of Bordeaux, France
(3) Fundamental Microbiology and Pathogenicity Laboratory UMR-CNRS 5234 – University of Bordeaux, France
(4) Microbiology department, Bordeaux university hospital (CHU de Bordeaux), France

 
Fecal microbiota transplantation: from the raw material to the pharmaceutical preparation
R.BATISTA, Service de pharmacie, Hôpitaux Universitaires Paris Centre, Assistance Publique – Hôpitaux de Paris

 
Theranostics and radiopharmacy: a technical example of neuroendocrine tumour management (Gallium-68 ; Lutetium 177)
F. Debordeaux,
Nuclear medicine department, University Hospital Bordeaux

 
Man to Mars with an artificial ecosystem
C. Lasseur, European Space Agency & Partenaires MELiSSA

Find out more

2018 Conference

 
Paediatric formulations provided by hospital pharmacies
Dr Andy Lowey
Lead Clinician - Clinical Pharmacy & Preparative Services, Leeds Teaching Hospitals NHS Trust, UK

Research in the field of paediatric drug formulation
Dr F. Marçon^1,2
1. Pharmacie à Usage Intérieur, département conception, fabrication et contrôle du médicament, CHU Amiens- Picardie, Amiens, France.
2. Laboratoire AGIR EA 4294, Université de Picardie Jules Verne, Amiens, France

The PaedForm project
Helin-Tanninen
Minna (Kuopio University Hospital, Kuopio, Finland)

 
Advanced Therapy Medicinal Products (ATMPs)
Moderator: Pr S. Crauste-Manciet, CHU Bordeaux

Dr L. Escalup, Institut Curie, Paris, France
Pr P. Odou, CHRU Lille, France
Dr I. Madelaine, CHU Saint-Louis, Paris, France
Dr A. Black, Hôpital Newcastle, UK
Dr C. Bernard, CHU Pitié-Salpêtrière, Paris, France

 
Nanoemulsion for Magnetic Hyperthermia in Oncology
H. Mazaré¹, G. Prévot¹, S. Mornet², O. Sandre⁴,F. Couillaut ³, S. Crauste-Manciet¹
1 ARNA laboratory, Univ. Bordeaux, INSERM, U1212, CNRS, UMR 5320, F-33000 Bordeaux, France
2 ICMCB, Univ. Bordeaux, CNRS, UPR 9048, F-33600 Pessac, France
3 IMOTION, EA 7435, Univ. Bordeaux, F-33000 Bordeaux, France
4 LCPO, Univ. Bordeaux, INP-ENSCBP, CNRS, UMR 5629, F-33607 Pessac, France

 
Microbiological stability of hydrochlorothiazide and spironolactone oral suspension coumpounded with additives-free suspending vehicule
C. Sanchez ¹, K. Beuzit¹, A. Bousseau², A. Dupuis ^1-3,F. G. Binson ^1-3
1 Pharmacy, Poitiers Teaching Hospital, Poitiers, France
2 Hygiene unit, Poitiers Teaching Hospital, Poitiers, France
3 INSERM cic 1402 hedex, University of Poitiers, Poitiers, France

 
Pharmaceutical Technology: Imperatives and Opportunities
Alexander T. Florence
UCL School of Pharmacy, University College London, London WC1N, UK

 
Pilot Study Evaluating the Efficacy of Four Cleaning Solutions and Two Types of Mops in Delimited Areas of a Floor Contaminated with Cyclophosphamide
Roland C¹, Adé A¹, Ouellette-Frève JF², Caron N³, Bussières JF^1,4

1 Pharmacy Practice Research Unit, CHU Sainte-Justine, Montréal, Québec, Canada
2 Oncology Pharmacy Department, CHU Sainte-Justine, Montréal, Québec, Canada
3 Quebec Toxicology Center, Institut national de santé publique du Québec, Québec, Québec, Canada
4 Faculty of Pharmacy, Montréal University, Montréal, Québec, Canada

 
Particulate contamination of solutions
Pr P. Odou
GRITA - Faculty of Pharmacy – Lille University and Hospital University of Lille

 
Terrorist chemical threat: research and operational countermeasures
Christophe Piérard, PhD, HDR
Unité Vésicants – Département Toxicologie et Risques Chimiques
Institut de Recherche Biomédicale des Armées
B.P. 73 – 91223 Brétigny-sur-Orge Cedex, France

 
Development of a unit dose drug distribution robot project in a GHT
H. Bontemps, M. Boudelin
GHT Rhône Nord Beaujolais Dombes Beaujolais

 
Automation of dose preparation to be administered, what solutions for which objectives ?
J. Duceau
Assistant pharmacist, CHR Orléans

Find out more

Testimonials

Interviews with speakers and participants at our scientific days

- Richard BATEMAN, Q.A.S.Ph, Newcastle - UNITED KINGDOM

- Alison BEANEY, R.Q.A.Sp – Newcastle – UNITED KINGDOM

- Philip CHENNELL, CHU Clermont-Ferrand – FRANCE

- Thomas CONNOR, National Institute For Occupational Safety and Heath – Cincinnati - USA

- Julia GILMARTIN, University College - London – UNITED KINGDOM

- Laurence GOLDBERG, Press Consultant Pharmacist at Laurence A Goldberg Ltd Tottington Greater Manchester - UNITED KINGDOM

- Pr Irène KRAMER, University Medical center – Mainz – GERMANY

- Carmen LOPEZ – CABEZAS, Hôpital Clinic Barcelona – Barcelona – SPAIN

- Ana Maria MARTIN de ROSALES, Foundation University Hospital – Alcorcon – SPAIN

- Dr Rudolf SCHIERL, Institute for Occupationnal Social and Environmental Medicine University Hospital Munich Campus Innenstadt, Munich - GERMANY

- Julian SMITH, Meridian Pharma. Ltd, Cardiff (Walles) - UNITED KINGDON

Find out more